Back

Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant cell biology and therapy response

Araos Henriquez, J.; Jihad, M.; Jassim, A.; Lloyd, E. G.; Luo, W.; Manansala, J. S.; Harish, S.; Pinto Teles, S.; Cheng, P. S.; Mucciolo, G.; Li, W.; Zaccaria, M.; Mukherjee, D.; Brais, R.; Mills, S.; Johnson, P. M.; Vallespinos, M.; Gilbertson, R. J.; Biffi, G.

2026-02-03 cancer biology
10.64898/2026.02.02.703350 bioRxiv
Show abstract

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis and is characterised by an extensive pro-tumorigenic stroma. Although most PDAC cases occur in older patients, the impact of ageing on malignant-stromal interactions and therapy response remains poorly understood. Here, we established orthotopically-grafted organoid-derived PDAC models across three murine age groups to characterise changes in the PDAC stroma and malignant cells with ageing. Cross-species analyses of tumour transcriptomes using a graph-embedding approach showed that integrating mouse models of different ages better captures the diversity of human PDAC, and that aged models more faithfully recapitulate the biology of older patients with PDAC. We also demonstrated that aged PDAC models have a more inflammatory stroma than that of younger tumours, shaping the malignant cell transcriptome. Finally, graph-embedding identified IRAK4 as a candidate therapeutic vulnerability in aged, but not young, KRAS- and p53-mutant PDAC, which we validated in preclinical drug studies. These findings highlight how ageing is a critical determinant of PDAC biology and associated therapeutic vulnerabilities, which should be an important consideration when designing disease models for preclinical development of precision therapies.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
10.5%
2
Nature Communications
4913 papers in training set
Top 17%
10.2%
3
Cell Reports
1338 papers in training set
Top 5%
7.2%
4
Developmental Cell
168 papers in training set
Top 4%
4.9%
5
Nature Aging
51 papers in training set
Top 0.4%
4.0%
6
Cancer Cell
38 papers in training set
Top 0.4%
3.6%
7
Gut
36 papers in training set
Top 0.2%
3.6%
8
Scientific Reports
3102 papers in training set
Top 43%
2.8%
9
Cancer Research
116 papers in training set
Top 1%
2.4%
10
Communications Biology
886 papers in training set
Top 6%
1.9%
50% of probability mass above
11
eLife
5422 papers in training set
Top 38%
1.9%
12
Cell Stem Cell
57 papers in training set
Top 1%
1.8%
13
Genome Medicine
154 papers in training set
Top 4%
1.8%
14
Cell Death & Disease
126 papers in training set
Top 0.9%
1.7%
15
Cancers
200 papers in training set
Top 3%
1.7%
16
Cancer Discovery
61 papers in training set
Top 1%
1.5%
17
Advanced Science
249 papers in training set
Top 12%
1.5%
18
Molecular Oncology
50 papers in training set
Top 0.5%
1.3%
19
Gastroenterology
40 papers in training set
Top 1%
1.3%
20
The EMBO Journal
267 papers in training set
Top 3%
1.2%
21
iScience
1063 papers in training set
Top 21%
1.2%
22
Cell Reports Medicine
140 papers in training set
Top 5%
1.2%
23
The Journal of Pathology
22 papers in training set
Top 0.3%
1.1%
24
eBioMedicine
130 papers in training set
Top 2%
1.1%
25
Science Advances
1098 papers in training set
Top 25%
1.0%
26
Frontiers in Oncology
95 papers in training set
Top 3%
0.9%
27
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
28
JCI Insight
241 papers in training set
Top 6%
0.9%
29
Nature Cancer
35 papers in training set
Top 1%
0.8%
30
British Journal of Cancer
42 papers in training set
Top 1%
0.8%